News

Video | Q&A with Paul Kase, SVP, Commercial Operations

12 July 2024

In this Q&A with Paul Kase, Lumos’ SVP, Commercial Operations, Paul outlines how Lumos is working in partnership with Henry Schein to access key global markets, and the imminent availability of FebriDx® to Australian healthcare practitioners as Australia enters its peak flu season.

Take a look:

Related news

Lumos commences FebriDx® CLIA waived pediatric study

22 October 2025

Proactive Interview with CFO Barrie Lambert

29 September 2025

Inquire now

We are inviting qualified B2B Service inquiries for those seeking to develop point-of-care reader technology

By entering your email address you are agreeing to our Privacy Policy.

Innovation at the point-of-care

2024 Lumos Diagnostics